ivWatch

ivWatch is redefining IV therapy safety. The world’s only continuous IV monitoring system is clinically proven to detect infiltration and extravasation events before visible signs appear, ivWatch helps prevent severe IV harm before it happens. Backed by decades of research and clinical validation, ivWatch continuously monitors IV site integrity in high-risk care settings. IV therapy is one of the most common procedures in healthcare, yet studies show up to 50% of IVs fail before treatment is complete, resulting in pain, tissue injury, prolonged hospital stays, and higher costs. Using a non-invasive sensor technology and a predictive algorithm, ivWatch empowers clinical teams to intervene early, improve patient outcomes, reduce liability, and drive cost savings—setting a new standard of care for IV therapy. Our mission is bold: STOP IV HARM. Watch the video and schedule a demo to see ivWatch in action: ivwatch.com/request-a-demo/ #IVSafety #PatientSafety #HealthcareInnovation #MedTech #NursingTechnology #InfiltrationDetection #ContinuousMonitoring #ClinicalExcellence #HospitalSafety #VascularAccess #InfusionTherapy #AvoidableHarm

ivWatch is excited to announce our inclusion in the @NHSSupplyChain Innovation Products Pathway in the United Kingdom — progressing through review on an accelerated basis to give NHS Trusts faster access to continuous IV monitoring for early detection of IV infiltration and extravasation events. Peripheral IV therapy is one of the most common procedures across the NHS, yet IV injuries remain far too frequent. With the right technology, that trajectory can change. Severe IV injury harm is preventable — and the NHS is recognizing that safeguarding patients must remain a top priority. Maya Aquino-Guerrero @CNS_IVnurse, Patient Safety Champion at NHS Supply Chain and National IV and Vascular Access Safety Initiative Board Member, shared: "In my ongoing efforts to elevate patient safety standards across the NHS, I’ve seen firsthand how early detection technologies like ivWatch can transform IV care. Extravasation injuries are not only painful, but often avoidable with timely intervention. ivWatch’s ability to provide continuous, real-time monitoring empowers clinicians to act quickly, preventing harm and reducing costly complications. This technology embodies the kind of innovation we need to protect patients and ensure the best use of NHS resources." This milestone helps fast-track proven innovation into frontline care — empowering clinicians, protecting patients, and strengthening IV safety across England. Read more: ivwatch.com/2026/03/19/ivw… #NHSSupplyChain #NHS #PatientSafety #IVSafety #ExtravasationPrevention #InfusionTherapy #ClinicalInnovation #MedTech #HealthcareQuality #ProtectEveryPatient @IV_Nurse

Peripheral IV infiltration and extravasation events (PIVIEs) remain one of the most common complications in patient care, yet they are rarely tracked with consistency. Different units document differently. Severity gets graded inconsistently. Some events aren’t logged until they become severe. The result? A massive visibility gap. Hospitals don’t know their true PIVIE rate—and that means preventable harm stays hidden. Standardizing post‑event reporting is the simplest, most impactful first step. A unified form captures the essentials: site, medication, severity, time to detection, symptoms, treatment, and outcome. When every unit reports the same way, real patterns finally emerge. Hospitals that start this process uncover the truth quickly—high‑risk meds, vulnerable populations, and units with elevated rates. From there, strong organizations build PIVIE committees, strengthen protocols, and drive meaningful improvement. Because preventing IV injuries starts with seeing them. Read the full article: ivwatch.com/2026/03/17/why… Download the standardized Post‑PIVIE Reporting Form: ivwatch.com/wp-content/upl… #PatientSafety #IVTherapy #VascularAccess #Extravasation #IVInfiltration #QualityImprovement #ivWatch

The future of IV safety. Our miniaturized sensor brings real-time precision and a smarter, safer standard to IV therapy. Key Benefits: • Advanced Monitoring: Continuously surveils the IV site to detect extravasations early. • Real-Time Alerts: Immediately notifies clinical teams, enabling rapid intervention. • Enhanced Accuracy: Powered by patented algorithms that provide precise, predictive IV insights. • Cost-Conscious Impact: Helps reduce IV-related complications, lowering costs and potentially shortening length of stay. Safer IV therapy starts with better visibility. Learn more about technology: ivwatch.com/tech-overview/ #ivWatch #PatientSafety #ClinicalInnovation #HealthcareTechnology #MedTech #IVTherapy #SaferCare

From the smallest patients in neonatal and pediatric units to adult and critical care populations, IV safety matters at every stage of life. Across the country we're partnering with clinicians, nursing leaders, risk teams, and executives who are committed to reducing preventable IV harm. What we see everywhere is the same: Dedicated care teams. Complex patient needs. And a shared desire to detect infiltrations and extravasations earlier. Whether in pediatrics or adult populations, the goal is consistent — protect patients, support clinicians, and strengthen outcomes. We’re proud to stand alongside healthcare teams who refuse to accept IV complications as “just part of the process.” #IVTherapy #PatientSafety #HealthcareInnovation #ClinicalExcellence #IVMonitoring #PreventableHarm #EarlyDetection #ivWatch

Antidotes in IV therapy aren’t prevention. They’re reactive. Hospitals rely on them to treat IV infiltrations and extravasations after injury occurs. That means patient harm happens first, then clinicians respond. PIVIEs aren’t limited to ICU or oncology—they happen anywhere IVs are used. Early detection is the only strategy that can truly prevent serious tissue damage. At ivWatch, we bring real-time visibility to every peripheral IV, giving clinicians the tools to act before harm escalates. Prevention starts with insight, not reaction. Read the full story: ivwatch.com/2026/02/09/ant… #PatientSafety #IVTherapy #ClinicalExcellence #MedTech #IVWatch

ivWatch is proud to partner with Aon, a leading global insurance broker and risk consultant to quantify the financial and clinical impact through a validated, data-driven ROI analysis for IV infiltration and extravasation events. This collaboration brings together clinical data and ivWatch innovation combined with real healthcare liability, cost, claims, and benchmarking data. By combining strong clinical efficacy with Aon’s proprietary insights, the model evaluates the projected financial and operational impact of implementing ivWatch in both pediatric and adult hospital settings. The analysis goes beyond a single injury or equipment cost. It captures the often-overlooked financial consequences of IV extravasation events including: •Liability exposure •Uncompensated care •Extended treatment costs •Operational disruption •Patient satisfaction impact Patient safety and fiscal responsibility are no longer competing priorities — they are aligned. Read more about how ivWatch can help your institution quantify the most underreported event in healthcare: ivwatch.com/2026/03/09/ivw… #HealthcareFinance #CFO #PatientSafety #IVSafety #RiskManagement

Hospitals track CLABSIs relentlessly through dashboards, penalties, and public reporting. Yet one of the most common causes of preventable harm still happens quietly, peripheral IV infiltrations and extravasations (PIVIEs). Not because they’re rare. Because no one is required to count them. As central line use declines, risk has shifted to peripheral IVs—often delivering high-risk medications without standardized tracking or visibility. What isn’t measured isn’t managed. Severe tissue injury isn’t inevitable. Late detection is the problem. The most dangerous harm in the hospital isn’t always the most visible— it’s the one happening quietly because no one is watching. Read more: ivwatch.com/2026/02/27/the… #IVSafety #PatientSafety #HealthcareQuality #MedTech #ClinicalExcellence #NursingLeadership

Ever had a patient roll over on their IV or a child pull on their IV tubing? This is a common infiltration when the catheter becomes dislodged from the vein. What to expect: • Fairly rapid onset of symptoms of all the infusing fluids leaking or pooling into the subcutaneous tissue. • Flushing the IV with normal saline or aspirating for blood return will provide immediate indications of an infiltration.

We took a chance and brought visibility to IV injuries—sharing real images of devastating patient harm to spark an important conversation. At trade shows, we were asked to censor them. On social platforms, the content was flagged as “disturbing.” But if IV infiltration remains hidden and underreported, how do we have an honest dialogue about patient safety? And more importantly—how do we advance meaningful solutions? Progress starts with transparency. We cannot improve what we are unwilling to confront. #IVSafety #PatientSafety #HealthcareTransparency #IVInfiltration #ExtravasationAwareness #PreventableHarm #ClinicalEducation #HealthcareInnovation #MedTech #HospitalSafety

Clinicians are advised to monitor chemotherapy infusions every 5 to 10 minutes due to the severe and potentially life-threatening harm that can occur from an extravasation. But how often is this reality? With continuous monitoring of 5 times per second, we offer a patients and clinicians peace of mind between periodic assessments. Help give these patients one less thing to worry about and be an advocate towards detecting the inevitable. Source from: pmc.ncbi.nlm.nih.gov/articles/PMC47… #VascularAccess #PeripheralIV #IVExtravasation #IVInfiltration

At ivWatch, our mission is to help safeguard clinicians and their patients through innovative technology. This mini sensor is defined by accuracy, offering a smarter, safer approach to IV therapy. Key Benefits Include: •Advanced Monitoring: Continuously monitors the IV site, detecting extravasations early before visible signs are often present. •Real-Time Alerts: Provides immediate notifications to healthcare providers, ensuring timely intervention. •Enhanced Accuracy: Utilizes patented algorithms to deliver precise and predictive IV insights •User-Friendly Interface: Easy to integrate into existing workflows, with intuitive controls that simplify checking IVs. •Cost-Effective: Reduces the incidence of IV-related complications, leading to significant cost savings and reduced lengths of stay. Learn more: ivwatch.com/tech-overview/ #VascularAccess #IVInfiltration #IVExtravasation #InfusionTherapy #ivWatch

"I’ve been here since the earliest prototypes, and what distinguishes ivWatch from other technologies is not just innovation—it’s validation. From our first FDA submission supported by Cincinnati Children’s clinical data to independent third-party studies confirming performance in real-world settings, we have built this technology on evidence. That foundation is what allows us to continue expanding the platform with confidence."

ivWatch isn’t just a product—it’s a long-term commitment. Beyond precision IV safety technology, our clinical experts provide continuous, hands-on support to help facilities sustain and advance IV therapy quality over time. From education to workflow integration, we work alongside clinicians to drive lasting improvement. Our support is tailored to each facility and includes: • Superuser training • In-service days • Clinical rounding • Educational workshops • Digital learning modules • Study days and staff development sessions We’re here to elevate IV therapy standards, strengthen clinical confidence, and improve patient safety—today and long term. #IVSafety #PatientSafety #HealthcareInnovation #EarlyDetection #ivWatch

THE IV SAFETY MOVEMENT IS GAINING MOMENTUM The energy at the 2026 IV Therapy Summit was unmistakable, as clinicians united around a shared priority: preventing avoidable harm from infiltration and extravasation injuries. Through stronger alignment with national standards and better support for frontline clinicians in early detection and intervention, IV safety is moving beyond discussion into action. What was once a local hospital priority is now embedded as an NHS standard. The transition from reactive response to proactive prevention marks a powerful and necessary shift in patient safety culture. #IVSafety #PatientSafety #Extravasation #Infiltration #IVTherapy #ivWatch #HealthcareInnovation #TheIVTherapySummit

All patients worldwide who receive IV therapy are at inherent risk of infiltration or extravasation. Advancing IV safety requires challenging the current standard and evolving with new best practices, learnings, and evidence-based innovation. Join us and commit to advancing clinical excellence, and enhancing patient safety: ivwatch.com